THE rare good news from Covid is that the pandemic has spawned new cancer vaccine research and trials.
Prospects of success appear to be good. BioNTech co-founders Ugur Sahin and Ozlem Tureci, who lead the way with messenger RNA (mRNA) Covid … Read the rest